(Q43470680)

23 November 2017

Prevalence of metabolic syndrome in Behçet disease: a case-control study in Turkey (English)

1 reference

23 November 2017

0 references

1 reference

Başak Yalçın

1

1 reference

23 November 2017

Güneş Gür

series ordinal

2

1 reference

23 November 2017

Ferda Artüz

series ordinal

3

1 reference

23 November 2017

Nuran Allı

series ordinal

4

1 reference

23 November 2017

1 October 2013

1 reference

American Journal of Clinical Dermatology

23 November 2017

1 reference

23 November 2017

14

1 reference

23 November 2017

5

1 reference

23 November 2017

421-425

1 reference

https://scigraph.springernature.com/pub.10.1007/s40257-013-0034-8

23 November 2017

0 references

cites work

Patient characteristics in Behçet disease: a retrospective analysis of 213 Turkish patients during 2001-4.

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

New insights into the pathogenesis of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

The functional role of nuclear factor kappa-kappaB1 -94 ins/del ATTG promotor gene polymorphism in Behçet's disease: an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

Metabolic syndrome: definition and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

Prevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

Increased insulin resistance and serum resistin in Korean patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

New insights in the clinical understanding of Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

Increased erythrocyte aggregation as an indicator for an aggressive clinical course in Behçet's disease: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

Mortality in Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

Prevalence and correlates of the metabolic syndrome in a population-based sample of European youth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

The role of lifestyle change in the prevention and treatment of NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

Contribution of adipocyte-derived factors to beta-cell dysfunction in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0034-8

10.1007/S40257-013-0034-8

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference